These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19641919)

  • 1. Evaluation of the exposure equivalence of oral versus intravenous temozolomide.
    Diez BD; Statkevich P; Zhu Y; Abutarif MA; Xuan F; Kantesaria B; Cutler D; Cantillon M; Schwarz M; Pallotta MG; Ottaviano FH
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):727-34. PubMed ID: 19641919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Open-Label, Two-Way Crossover, Single-Dose Bioequivalence Study of Temozolomide 200 mg/m
    Muggeri A; Vago M; Pérez S; Rubio M; González C; Magariños C; Rosenberg M; Costa F; Pérez-Lloret S
    Drugs R D; 2017 Sep; 17(3):427-434. PubMed ID: 28756607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of temozolomide using an extended continuous oral schedule.
    Brock CS; Newlands ES; Wedge SR; Bower M; Evans H; Colquhoun I; Roddie M; Glaser M; Brampton MH; Rustin GJ
    Cancer Res; 1998 Oct; 58(19):4363-7. PubMed ID: 9766665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic study of temozolomide on a daily-for-5-days schedule in Japanese patients with relapsed malignant gliomas: first study in Asians.
    Aoki T; Nishikawa R; Mizutani T; Nojima K; Mishima K; Adachi J; Matsutani M
    Int J Clin Oncol; 2007 Oct; 12(5):341-9. PubMed ID: 17929115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
    Middleton MR; Grob JJ; Aaronson N; Fierlbeck G; Tilgen W; Seiter S; Gore M; Aamdal S; Cebon J; Coates A; Dreno B; Henz M; Schadendorf D; Kapp A; Weiss J; Fraass U; Statkevich P; Muller M; Thatcher N
    J Clin Oncol; 2000 Jan; 18(1):158-66. PubMed ID: 10623706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer.
    Dhodapkar M; Rubin J; Reid JM; Burch PA; Pitot HC; Buckner JC; Ames MM; Suman VJ
    Clin Cancer Res; 1997 Jul; 3(7):1093-100. PubMed ID: 9815788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
    Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
    Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.
    Brada M; Judson I; Beale P; Moore S; Reidenberg P; Statkevich P; Dugan M; Batra V; Cutler D
    Br J Cancer; 1999 Nov; 81(6):1022-30. PubMed ID: 10576660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).
    Patel PM; Suciu S; Mortier L; Kruit WH; Robert C; Schadendorf D; Trefzer U; Punt CJ; Dummer R; Davidson N; Becker J; Conry R; Thompson JA; Hwu WJ; Engelen K; Agarwala SS; Keilholz U; Eggermont AM; Spatz A;
    Eur J Cancer; 2011 Jul; 47(10):1476-83. PubMed ID: 21600759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of temozolomide for recurrent embryonal brain tumors in children.
    Wang CH; Hsu TR; Wong TT; Chang KP
    Childs Nerv Syst; 2009 May; 25(5):535-41. PubMed ID: 19107490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of gastric pH on the relative oral bioavailability and pharmacokinetics of temozolomide.
    Beale P; Judson I; Moore S; Statkevich P; Marco A; Cutler DL; Reidenberg P; Brada M
    Cancer Chemother Pharmacol; 1999; 44(5):389-94. PubMed ID: 10501912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioequivalence study of 20-mg and 100-mg temozolomide capsules (TOZ309 and Temodal
    Hu C; Lin Q; Liu C; Liu J; Chen X; Li X; Zhao G; Zhang L
    Cancer Chemother Pharmacol; 2020 Dec; 86(6):793-801. PubMed ID: 33089408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a pharmacokinetic limited sampling model for temozolomide and its active metabolite MTIC.
    Kirstein MN; Panetta JC; Gajjar A; Nair G; Iacono LC; Freeman BB; Stewart CF
    Cancer Chemother Pharmacol; 2005 May; 55(5):433-8. PubMed ID: 15818507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and pharmacokinetics of temozolomide in rat.
    Reyderman L; Statkevich P; Thonoor CM; Patrick J; Batra VK; Wirth M
    Xenobiotica; 2004 May; 34(5):487-500. PubMed ID: 15370964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer.
    Baker SD; Wirth M; Statkevich P; Reidenberg P; Alton K; Sartorius SE; Dugan M; Cutler D; Batra V; Grochow LB; Donehower RC; Rowinsky EK
    Clin Cancer Res; 1999 Feb; 5(2):309-17. PubMed ID: 10037179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I and pharmacokinetic study of temozolomide on a daily-for-5-days schedule in patients with advanced solid malignancies.
    Hammond LA; Eckardt JR; Baker SD; Eckhardt SG; Dugan M; Forral K; Reidenberg P; Statkevich P; Weiss GR; Rinaldi DA; Von Hoff DD; Rowinsky EK
    J Clin Oncol; 1999 Aug; 17(8):2604-13. PubMed ID: 10561328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches for temozolomide therapy: use in newly diagnosed glioma.
    Stupp R; Newlands E
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):19-23. PubMed ID: 11550135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future directions for temozolomide therapy.
    Yung WK
    Semin Oncol; 2001 Aug; 28(4 Suppl 13):43-6. PubMed ID: 11550138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is protracted low-dose temozolomide feasible in glioma patients?
    Tosoni A; Cavallo G; Ermani M; Scopece L; Franceschi E; Ghimenton C; Gardiman M; Pasetto L; Blatt V; Brandes AA
    Neurology; 2006 Feb; 66(3):427-9. PubMed ID: 16476947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.